A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositisAdam Schiffenbauer, Mark F. Gourley, Galen O. Joe et al.|Seminars in Arthritis and Rheumatism|2017Cited by 70
The effect of cigarette smoking on the clinical and serological phenotypes of polymyositis and dermatomyositisAdam Schiffenbauer, Frederick W. Miller, Sara Faghihi‐Kashani et al.|Seminars in Arthritis and Rheumatism|2018Cited by 44